Durable responses to long-term selumetinib in Chinese pediatric NF1 patients with inoperable plexiform neurofibromas
BackgroundThis study provides the first long-term efficacy and safety data of selumetinib in Chinese pediatric patients with inoperable symptomatic plexiform neurofibromas (PN) associated with neurofibromatosis type 1 (NF1).MethodsIn this single-center Phase I clinical trial(NCT04590235), we enrolle...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2026-06-01
|
| Serier: | Frontiers in Pharmacology |
| Fag: | |
| Online adgang: | https://www.frontiersin.org/articles/10.3389/fphar.2026.1855171/full |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|